Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beta Bionics, Inc.(BBNX) | 429,120 | 2,500 | -426,620 | $5.25M | $6.25M | 37.57% | +$995.6K |
| Insight Molecular Diagnostics Inc.(IMDX) | 947,134 | 18,700 | -928,434 | $2.90M | $2.86M | 17.20% | -$37.9K |
| Caris Life Sciences, Inc.(CAI) | 0 | 45,000 | +45,000 | $0 | $2.40M | 14.45% | +$2.40M |
| Establishment Labs Holdings Inc.(ESTA) | 45,000 | 89,940 | +44,940 | $1.84M | $1.92M | 11.56% | +$85.7K |
| Outset Medical, Inc.(OM) | 5,000 | 429,120 | +424,120 | $783.4K | $1.36M | 8.18% | +$577.3K |
| InspireMD, Inc.(NSPR) | 450,517 | 450,517 | 0 | $1.21M | $1.02M | 6.15% | -$189.2K |
| Natera, Inc.(NTRA) | 2,500 | 245,691 | +243,191 | $353.5K | $422.4K | 2.54% | +$68.8K |
| Metagenomi Therapeutics, Inc.(MGX) | 264,391 | 952,134 | +687,743 | $359.6K | $391.3K | 2.35% | +$31.7K |
| Kestra Med Technologies LtdSHS SHS | 40,000 | 0 | -40,000 | $996.8K | $0 | — | -$996.8K |